Cargando…

Cost-effectiveness analysis of protease inhibitor monotherapy vs. ongoing triple-therapy in the long-term management of HIV patients

INTRODUCTION: Protease inhibitors might be sufficient to maintain complete virological suppression when used as monotherapy for HIV-1-positive patients who have achieved sustained virological suppression on combination antiretroviral therapy (ART). The present study estimated the cost-effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oddershede, Lars, Walker, Simon, Paton, Nicholas, Stöhr, Wolfgang, Dunn, David, Sculpher, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Oral Presentation – Abstract O217
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224943/ https://www.ncbi.nlm.nih.gov/pubmed/25394007 http://dx.doi.org/10.7448/IAS.17.4.19498

Ejemplares similares

Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy
por: Dunn, David T., et al.
Publicado: (2018)

Using cost-effectiveness analysis to support decision making in resource poor settings: methods and practical challenges
por: Sculpher, Mark
Publicado: (2014)

Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis
por: Bierman, WFW, et al.
Publicado: (2010)

New dolutegravir resistance pattern identified in a patient failing antiretroviral therapy
por: Carganico, Andreas, et al.
Publicado: (2014)

Cost-effectiveness of magnetic resonance imaging in coronary heart disease: an economic evaluation using data from the CE-MARC study
por: Greenwood, John P, et al.
Publicado: (2013)

Rational allocation of resources available for healthcare: understanding cost effectiveness analyst
por: Briggs, Andrew
Publicado: (2014)

First prospective comparison of genotypic vs phenotypic tropism assays in predicting virologic responses to Maraviroc (MVC) in a phase 3 study: MODERN
por: Heera, Jayvant, et al.
Publicado: (2014)

Ongoing validation of health-related quality of life instruments
por: Cocks, Kim, et al.
Publicado: (2015)

The state of PI monotherapy and NRTI-sparing therapy
por: Arribas, JR
Publicado: (2010)

20 years of developing European standards. Fieldwork and ongoing dialogue with governments
por: Pimenoff, Veronica
Publicado: (2007)

Ongoing Health Care Expenditure in Survivors of Sepsis in The Intensive Care Unit
por: Koster-Brouwer, M, et al.
Publicado: (2015)

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial
por: Paton, Nicholas I, et al.
Publicado: (2015)

Augmentation colocystoplasty and incontinence surgery in patients with spina bifida – our ongoing experience
por: Kumar, Prashanth, et al.
Publicado: (2010)

O031. Physiotherapy treatment in chronic tension-type headache: an ongoing study
por: Monticco, Antonella, et al.
Publicado: (2015)

Ongoing seasonal intestinal inflammation in birch pollen allergic patients without gastrointestinal symptoms
por: Rentzos, Georgios, et al.
Publicado: (2011)

Airway function in adults with mild-to-moderate scoliosis treated in adolescence with specific physical exercises. An ongoing, case-control study
por: Plaszewski, M, et al.
Publicado: (2012)

Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa
por: Pillay, D, et al.
Publicado: (2010)

Evaluation of patient reported outcomes following pain management programmes delivered via video conferencing during the Covid-19 pandemic
por: Heelas, L., et al.
Publicado: (2022)

Out of hospital cardiac arrest (OHCA) patients without return of spontaneous circulation (ROSC) – should they be transported with ongoing resuscitation to the hospital?
por: Lindner, TW, et al.
Publicado: (2009)

The effects of a 6-month Schroth intervention for Adolescent Idiopathic Scoliosis (AIS): preliminary analysis of an ongoing randomized controlled trial
por: Schreiber, Sanja, et al.
Publicado: (2013)

Molecular classification of triple-negative tumors
por: Prat, A, et al.
Publicado: (2011)

Absence vs. presence
por: Ramkumar, Swaminathane
Publicado: (2014)

Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial
por: Clumeck, N, et al.
Publicado: (2010)

HIV Gag and PR: partners in resistance to protease and maturation inhibitors
por: Nijhuis, Monique
Publicado: (2011)

Enhancing patient self-management
por: Volny-Anne, Alain
Publicado: (2014)

Determinants of IL-6 levels during HIV infection
por: Borges, Álvaro H, et al.
Publicado: (2014)

Resistance: what is new and on the horizon, and a time to teach old dogs new tricks?
por: Schapiro, Jonathan
Publicado: (2014)

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Drug use, HIV, HCV and TB: major interlinked challenges in Eastern Europe and Central Asia
por: Kazatchkine, Michel
Publicado: (2014)

The cascade of HIV care in Russia, 2011–2013
por: Pokrovskaya, Anastasia, et al.
Publicado: (2014)

Adverse events: ART and the kidney: alterations in renal function and renal toxicity
por: Post, Frank
Publicado: (2014)

Integrated care pathways and task shifting
por: Panton, Linda
Publicado: (2014)

Cenicriviroc blocks HIV entry but does not lead to redistribution of HIV into extracellular space like maraviroc
por: Kramer, Victor, et al.
Publicado: (2014)

CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression
por: Costagliola, Dominique, et al.
Publicado: (2014)

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2014)

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study
por: Garcia, Federico, et al.
Publicado: (2014)

Effects of age on symptom burden, mental health and quality of life amongst people with HIV in the UK
por: McGowan, Jennifer, et al.
Publicado: (2014)

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort
por: Rokx, Casper, et al.
Publicado: (2014)

Managing first-line failure
por: Cooper, David A
Publicado: (2014)

Darunavir pharmacokinetics throughout pregnancy and postpartum
por: Lambert, John, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gdp1k715ud2n4gan5km54a1h45